<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01088412</url>
  </required_header>
  <id_info>
    <org_study_id>2712</org_study_id>
    <secondary_id>B9R-EW-GDFC</secondary_id>
    <nct_id>NCT01088412</nct_id>
  </id_info>
  <brief_title>Observational Study of Somatropin Treatment in Children</brief_title>
  <acronym>GeNeSIS</acronym>
  <official_title>The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      GeNeSIS is an open-label, multinational, multicenter, observational study to evaluate the
      safety and effectiveness of Humatrope treatment.

      GeNeSIS is a modular program that includes:

        -  Core study: Evaluating the safety and effectiveness of Humatrope in the observational
           setting

        -  Genetic Analysis Sub-study: Investigating the genetic defects underlying growth hormone
           (GH) deficiency and non-GH-deficient growth disorders

        -  Growth Prediction Sub-study: Working to validate and refine specific models to
           accurately predict growth response to GH

        -  Short Stature Homeobox containing gene (SHOX) Deficiency Sub-study: Elucidating the
           clinical, endocrine and radiological features of participants with SHOX deficiency due
           to loss of, or mutation in the SHOX gene (including participants with Turner syndrome)

        -  Neoplasia Sub-study: To characterize the natural history of neoplastic disease,
           especially in relation to recurrence/progression of primary neoplasia or development of
           secondary neoplasia in children with a history of neoplasia
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 1999</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Type 2 Diabetes Mellitus in GH-treated Participants</measure>
    <time_frame>Year 15</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Malignancies in Participant Without Previous Cancer History</measure>
    <time_frame>Year 15</time_frame>
    <description>Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Final Height (FH) Gain by Diagnostic Group</measure>
    <time_frame>Baseline through Year 15</time_frame>
    <description>The standard deviation score (SDS) reports the number of standard deviations from the mean for age and sex for an individual measurement (normal range is -2 to +2 SDS). Height SDS is derived by subtracting the population mean from individual's height value and then dividing that difference by the population standard deviation. Greater height SDS values indicate greater height. Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Defects in Genes Associated With Pituitary Development</measure>
    <time_frame>Baseline through Year 15</time_frame>
    <description>Percentage of participants with genetic defects associated with pituitary development. Genes included but were not limited to GH1, Growth hormone releasing hormone receptor (GHRHR), Homeobox gene expressed in embryonic stem cells (HESX1), LIM homeobox 3 (LHX3), POU domain, class 1, transcription factor 1 (POU1F1), and Prophet of Pit1 (PROP1).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predicted First Year Height Gain Versus Actual First Year Height Gain</measure>
    <time_frame>Baseline through Year 15</time_frame>
    <description>The value for predicted and observed is of limited bearing, it is how each participant's predicted versus observed height gain compare and this is best estimated by the R-squared. An estimation parameter would not be a correct format for the R2 data. R2 can take value between 0 and 1 with values closer to 0 representing a poor fit while values closer to 1 representing a perfect fit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Final Height in Anthropometric Measures for Participants With SHOX Deficiency</measure>
    <time_frame>Baseline, Year 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Recurrent Neoplasms and Second Neoplasms in Childhood Cancer Survivors</measure>
    <time_frame>Baseline through Year 15</time_frame>
    <description>Percentage of participants with recurrence/progression of primary neoplastic disease and/or development of secondary neoplasms in childhood cancer survivors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With De Novo Neoplasms</measure>
    <time_frame>Baseline through Year 15</time_frame>
    <description>Percentage of participants with the development of de novo neoplastic disease with no history of prior neoplasia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Mellitus (DM) in Somatropin-Treated Children With Different Short Stature Diagnoses</measure>
    <time_frame>Baseline through Year 15</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">22845</enrollment>
  <condition>Growth Hormone (GH) Deficiency</condition>
  <condition>Short Stature Homeobox Containing Gene (SHOX) Deficiency</condition>
  <condition>SHOX Deficiency-related Disorder</condition>
  <condition>Non-GH-deficient Growth Disorders</condition>
  <arm_group>
    <arm_group_label>Treated</arm_group_label>
    <description>Participants treated with somatropin for improvement of growth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Untreated</arm_group_label>
    <description>Untreated participants with presence or history of neoplastic disease evaluated for endocrine or growth disorder or with any SHOX deficiency related disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Somatropin (recombinant deoxyribonucleic acid [rDNA] origin)</intervention_name>
    <description>Dose, frequency and duration at discretion of attending physician.</description>
    <arm_group_label>Treated</arm_group_label>
    <other_name>Humatrope</other_name>
    <other_name>LY137998</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      If participant consented a DNA sample is kept until the end of the study
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Clinics and private practices
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All participants participating in GeNeSIS must be enrolled in the core study. Participants
        for whom written consent to release information is provided may enter the core study if
        they meet any of the following inclusion guidelines:

          -  Treatment with Humatrope for improvement of growth.

          -  No treatment with somatropin in participants with a history of neoplasia or in those
             with any SHOX deficiency-related disorder.

        Exclusion Criteria:

          -  Participants with closed epiphyses are not eligible for GeNeSIS entry. However,
             participants may remain in the study if epiphyseal closure occurs during study
             participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)</last_name>
    <role>Study Director</role>
    <affiliation>Eli Lilly and Company</affiliation>
  </overall_official>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>February 25, 2010</study_first_submitted>
  <study_first_submitted_qc>March 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2010</study_first_posted>
  <results_first_submitted>September 28, 2016</results_first_submitted>
  <results_first_submitted_qc>February 11, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 13, 2019</results_first_posted>
  <last_update_submitted>February 11, 2019</last_update_submitted>
  <last_update_submitted_qc>February 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Growth Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treated</title>
          <description>Treatment with Humatrope for improvement of growth. Growth Hormone (GH) product.</description>
        </group>
        <group group_id="P2">
          <title>Untreated</title>
          <description>No treatment with Humatrope in participants with a history of neoplasia or in those with any short stature homeobox containing gene (SHOX) deficiency-related disorder .</description>
        </group>
        <group group_id="P3">
          <description>Treatment with Humatrope unknown.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22311"/>
                <participants group_id="P2" count="457"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Modified Evaluable (SME)</title>
              <participants_list>
                <participants group_id="P1" count="22294"/>
                <participants group_id="P2" count="456"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>SME With at Least 1 Follow Up (FU)</title>
              <participants_list>
                <participants group_id="P1" count="21178"/>
                <participants group_id="P2" count="306"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>SME+ &gt;= 1 FU and Unknown Arm</title>
              <participants_list>
                <participants group_id="P1" count="21177"/>
                <participants group_id="P2" count="306"/>
                <participants group_id="P3" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>SME+ &gt;= 1 FU and No Previous Cancer</title>
              <participants_list>
                <participants group_id="P1" count="20556"/>
                <participants group_id="P2" count="192"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>SME+ &gt;= 1 FU and Previous Cancer</title>
              <participants_list>
                <participants group_id="P1" count="622"/>
                <participants group_id="P2" count="114"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4294"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18017"/>
                <participants group_id="P2" count="436"/>
                <participants group_id="P3" count="72"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason per Case Report Form</title>
              <participants_list>
                <participants group_id="P1" count="2089"/>
                <participants group_id="P2" count="103"/>
                <participants group_id="P3" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1761"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Received Another GH Product</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Participant Moved</title>
              <participants_list>
                <participants group_id="P1" count="601"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1041"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor Decision</title>
              <participants_list>
                <participants group_id="P1" count="4467"/>
                <participants group_id="P2" count="79"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Third Party Required to Change Brand</title>
              <participants_list>
                <participants group_id="P1" count="487"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3052"/>
                <participants group_id="P2" count="130"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study Summary Not Completed</title>
              <participants_list>
                <participants group_id="P1" count="4360"/>
                <participants group_id="P2" count="64"/>
                <participants group_id="P3" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All enrolled participants.</population>
      <group_list>
        <group group_id="B1">
          <title>Treated</title>
          <description>Treatment with Humatrope for improvement of growth.</description>
        </group>
        <group group_id="B2">
          <title>Untreated</title>
          <description>No treatment with Humatrope in participants with a history of neoplasia or in those with any SHOX deficiency-related disorder.</description>
        </group>
        <group group_id="B3">
          <title>Unknown</title>
          <description>Treatment with Humatrope unknown.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22311"/>
            <count group_id="B2" value="457"/>
            <count group_id="B3" value="77"/>
            <count group_id="B4" value="22845"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>Age unavailable for 136 treated participants, 10 untreated participants, and 49 unknown participants.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21724"/>
                    <measurement group_id="B2" value="427"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="22178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="451"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="472"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <description>No gender available for 32 treated participants, 1 untreated participant, and 49 unknown participants.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8917"/>
                    <measurement group_id="B2" value="247"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="9175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13362"/>
                    <measurement group_id="B2" value="209"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="13588"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="959"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="977"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9279"/>
                    <measurement group_id="B2" value="166"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="9445"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12073"/>
                    <measurement group_id="B2" value="273"/>
                    <measurement group_id="B3" value="77"/>
                    <measurement group_id="B4" value="12423"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="260"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="263"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="295"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="303"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8328"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="8476"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13403"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="77"/>
                    <measurement group_id="B4" value="13778"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="850"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="870"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Czechia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="332"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1667"/>
                    <measurement group_id="B2" value="150"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="1821"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2685"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="2723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Greece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="290"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hungary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="332"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Iceland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>India</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="212"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="771"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="788"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2352"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="2356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Kazakhstan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lithuania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="90"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="317"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="320"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pakistan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="172"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Russia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="180"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Singapore</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slovakia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1404"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="1422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thailand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9812"/>
                    <measurement group_id="B2" value="160"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="10003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnostic Groups</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Chronic Renal Insufficiency (CRI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Growth Hormone Deficiency (GHD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14049"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="14173"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Idiopathic Short Stature (ISS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2844"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="2876"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Other Diagnostic Groups Not Listed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1226"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="1327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Born Small for Gestational Age (SGA)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1276"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1295"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX Deficiency (SHOX-D)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="576"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="705"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Turner Syndrome (TS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1870"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1913"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="383"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="469"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Type 2 Diabetes Mellitus in GH-treated Participants</title>
        <time_frame>Year 15</time_frame>
        <population>All treated participants with available age and calculable follow-up time. The treated participants were not compared with untreated but with rates from general population registries. The untreated participants predominantly contained neoplasm or SHOX deficient diagnoses, therefore had significant baseline differences from treated participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (recombinant deoxyribonucleic acid [rDNA] origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Type 2 Diabetes Mellitus in GH-treated Participants</title>
          <population>All treated participants with available age and calculable follow-up time. The treated participants were not compared with untreated but with rates from general population registries. The untreated participants predominantly contained neoplasm or SHOX deficient diagnoses, therefore had significant baseline differences from treated participants.</population>
          <units>Incident Cases</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21448"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ages 0 to 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ages 10 to 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ages 15 to 19</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.77</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.24</ci_lower_limit>
            <ci_upper_limit>5.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Malignancies in Participant Without Previous Cancer History</title>
        <description>Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</description>
        <time_frame>Year 15</time_frame>
        <population>All treated participants with available age, gender, and at least one follow-up excluding participants with previous cancer cases. Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with Humatrope for improvement of growth
Humatrope (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Malignancies in Participant Without Previous Cancer History</title>
          <description>Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</description>
          <population>All treated participants with available age, gender, and at least one follow-up excluding participants with previous cancer cases. Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</population>
          <units>Incident Cases</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of primary malignancies in study versus general population registry data, stratified by age and gender.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>1.20</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Final Height (FH) Gain by Diagnostic Group</title>
        <description>The standard deviation score (SDS) reports the number of standard deviations from the mean for age and sex for an individual measurement (normal range is -2 to +2 SDS). Height SDS is derived by subtracting the population mean from individual's height value and then dividing that difference by the population standard deviation. Greater height SDS values indicate greater height. Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</description>
        <time_frame>Baseline through Year 15</time_frame>
        <population>All treated participants who reached final height (at least 1: closed epiphyses, height velocity &lt;2 centimeters per year, or last bone age &gt;14 years [girls] or &gt;16 years [boys]) with baseline height SDS and final height available. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Final Height (FH) Gain by Diagnostic Group</title>
          <description>The standard deviation score (SDS) reports the number of standard deviations from the mean for age and sex for an individual measurement (normal range is -2 to +2 SDS). Height SDS is derived by subtracting the population mean from individual's height value and then dividing that difference by the population standard deviation. Greater height SDS values indicate greater height. Due to the small number of participants involved, untreated and unknown treatment groups, data was not provided and could not be calculated.</description>
          <population>All treated participants who reached final height (at least 1: closed epiphyses, height velocity &lt;2 centimeters per year, or last bone age &gt;14 years [girls] or &gt;16 years [boys]) with baseline height SDS and final height available. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
          <units>standard deviation score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5075"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5075"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.42" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5075"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.18" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5075"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.24" spread="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3079"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.35" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3080"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.96" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3079"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.39" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TS Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="695"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.65" spread=".089"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TS Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="695"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.70" spread="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TS Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="695"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.95" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ISS Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="552"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.37" spread="0.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ISS Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="552"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.26" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ISS Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="552"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.10" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX-D Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.36" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX-D Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.50" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX-D Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.86" spread="0.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SGA Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="265"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.57" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SGA Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="265"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.47" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SGA Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="265"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.11" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CRI Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.54" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CRI Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.66" spread="1.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CRI Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="300"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.70" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="300"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.69" spread="1.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="300"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.01" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown Baseline Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.30" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown Final Height</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.54" spread="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown Final Height Gain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Defects in Genes Associated With Pituitary Development</title>
        <description>Percentage of participants with genetic defects associated with pituitary development. Genes included but were not limited to GH1, Growth hormone releasing hormone receptor (GHRHR), Homeobox gene expressed in embryonic stem cells (HESX1), LIM homeobox 3 (LHX3), POU domain, class 1, transcription factor 1 (POU1F1), and Prophet of Pit1 (PROP1).</description>
        <time_frame>Baseline through Year 15</time_frame>
        <population>All SME participants (including treated, untreated, and unknown groups) with available results of DNA (deoxyribonucleic acid) analysis available and GHD diagnosis.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth with a history of neoplasia or in those with any short stature homeobox (SHOX)-related disorder.</description>
          </group>
          <group group_id="O2">
            <title>Untreated</title>
            <description>Participants not treated with a history of neoplasia or in those with any short stature homeobox (SHOX)-related disorder.</description>
          </group>
          <group group_id="O3">
            <title>Unknown</title>
            <description>Treatment with somatropin unknown.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Defects in Genes Associated With Pituitary Development</title>
          <description>Percentage of participants with genetic defects associated with pituitary development. Genes included but were not limited to GH1, Growth hormone releasing hormone receptor (GHRHR), Homeobox gene expressed in embryonic stem cells (HESX1), LIM homeobox 3 (LHX3), POU domain, class 1, transcription factor 1 (POU1F1), and Prophet of Pit1 (PROP1).</description>
          <population>All SME participants (including treated, untreated, and unknown groups) with available results of DNA (deoxyribonucleic acid) analysis available and GHD diagnosis.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="412"/>
                <count group_id="O3" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7"/>
                    <measurement group_id="O2" value="14.8"/>
                    <measurement group_id="O3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Predicted First Year Height Gain Versus Actual First Year Height Gain</title>
        <description>The value for predicted and observed is of limited bearing, it is how each participant's predicted versus observed height gain compare and this is best estimated by the R-squared. An estimation parameter would not be a correct format for the R2 data. R2 can take value between 0 and 1 with values closer to 0 representing a poor fit while values closer to 1 representing a perfect fit</description>
        <time_frame>Baseline through Year 15</time_frame>
        <population>All participants with predicted and actual first year height gain available and TS or GHD diagnosis. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted First Year Height Gain Versus Actual First Year Height Gain</title>
          <description>The value for predicted and observed is of limited bearing, it is how each participant's predicted versus observed height gain compare and this is best estimated by the R-squared. An estimation parameter would not be a correct format for the R2 data. R2 can take value between 0 and 1 with values closer to 0 representing a poor fit while values closer to 1 representing a perfect fit</description>
          <population>All participants with predicted and actual first year height gain available and TS or GHD diagnosis. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
          <units>R Squared</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="999"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="115"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.261"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="884"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.408"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Final Height in Anthropometric Measures for Participants With SHOX Deficiency</title>
        <time_frame>Baseline, Year 15</time_frame>
        <population>All SHOX-D Participants, GH-treated, with available height SDS at baseline and final height. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Final Height in Anthropometric Measures for Participants With SHOX Deficiency</title>
          <population>All SHOX-D Participants, GH-treated, with available height SDS at baseline and final height. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
          <units>standard deviation score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Height SDS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="144"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sitting Height (SH) SDS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arm Span (AS) SDS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SH SDS/Height SDS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AS SDS/Height SDS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AS SDS/SH SDS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="22.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Recurrent Neoplasms and Second Neoplasms in Childhood Cancer Survivors</title>
        <description>Percentage of participants with recurrence/progression of primary neoplastic disease and/or development of secondary neoplasms in childhood cancer survivors.</description>
        <time_frame>Baseline through Year 15</time_frame>
        <population>All SME, treated participants with previous neoplastic disease and at least one follow-up visit. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Recurrent Neoplasms and Second Neoplasms in Childhood Cancer Survivors</title>
          <description>Percentage of participants with recurrence/progression of primary neoplastic disease and/or development of secondary neoplasms in childhood cancer survivors.</description>
          <population>All SME, treated participants with previous neoplastic disease and at least one follow-up visit. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1087"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recurrences</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1087"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second Neoplasms</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="622"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With De Novo Neoplasms</title>
        <description>Percentage of participants with the development of de novo neoplastic disease with no history of prior neoplasia.</description>
        <time_frame>Baseline through Year 15</time_frame>
        <population>All SME, GH-treated participants with at least one follow-up visit. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With De Novo Neoplasms</title>
          <description>Percentage of participants with the development of de novo neoplastic disease with no history of prior neoplasia.</description>
          <population>All SME, GH-treated participants with at least one follow-up visit. Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20556"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Mellitus (DM) in Somatropin-Treated Children With Different Short Stature Diagnoses</title>
        <time_frame>Baseline through Year 15</time_frame>
        <population>All treated participants with available age and calculable follow-up time, and diabetes mellitus (DM), type 1 diabetes mellitus (T1) or type 2 diabetes mellitus (T2). Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Treated</title>
            <description>Participants treated with somatropin for improvement of growth
Somatropin (rDNA origin): Dose, frequency and duration at discretion of attending physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Mellitus (DM) in Somatropin-Treated Children With Different Short Stature Diagnoses</title>
          <population>All treated participants with available age and calculable follow-up time, and diabetes mellitus (DM), type 1 diabetes mellitus (T1) or type 2 diabetes mellitus (T2). Data was not provided for untreated and unknown treatment groups, and could not be calculated.</population>
          <units>Incident Cases</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21448"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21448"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13507"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TS DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1815"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ISS DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2645"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX-D DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="564"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SGA DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1111"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1488"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21448"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13507"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TS T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1815"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ISS T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2645"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX-D T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="564"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SGA T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1111"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1488"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown T1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21448"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GHD T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13507"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TS T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1815"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ISS T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2645"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SHOX-D T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="564"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SGA T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1111"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1488"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown T2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for All DM (T1, T2 and DM Not Otherwise Specified [NOS] Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.14</ci_lower_limit>
            <ci_upper_limit>4.15</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for GHD DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>2.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.72</ci_lower_limit>
            <ci_upper_limit>4.15</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for TS DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>4.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.80</ci_lower_limit>
            <ci_upper_limit>10.69</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for ISS DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.10</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>7.93</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for SHOX-D DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>11.83</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for SGA DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.36</ci_lower_limit>
            <ci_upper_limit>10.83</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for Other DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>4.55</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.24</ci_lower_limit>
            <ci_upper_limit>11.66</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for Unknown DM (T1, T2 and DM NOS Combined)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>24.30</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for All T1 DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.92</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.56</ci_lower_limit>
            <ci_upper_limit>1.44</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for GHD T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.36</ci_lower_limit>
            <ci_upper_limit>1.40</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for TS T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>1.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.31</ci_lower_limit>
            <ci_upper_limit>4.38</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for ISS T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>1.42</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.29</ci_lower_limit>
            <ci_upper_limit>4.14</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for SHOX-D T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>7.23</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for SGA T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>3.38</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for Other T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio]</param_type>
            <param_value>2.09</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.43</ci_lower_limit>
            <ci_upper_limit>6.10</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for Unknown T1DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio]</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>14.84</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for All T2 DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.24</ci_lower_limit>
            <ci_upper_limit>5.96</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for GHD T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.03</ci_lower_limit>
            <ci_upper_limit>6.87</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for TS T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>6.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.33</ci_lower_limit>
            <ci_upper_limit>18.89</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for ISS T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>7.52</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for SHOX-D T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>31.16</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for SGA T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>7.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>28.52</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for Other T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>3.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.08</ci_lower_limit>
            <ci_upper_limit>16.70</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Epidemiological comparison between incidence of type 2 diabetes in study versus general population registry data, stratified by age and ethnicity.
Standardized Incidence Ratio for Unknown T2DM.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Standardized Incidence Ratio</param_type>
            <param_value>0.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.00</ci_lower_limit>
            <ci_upper_limit>63.97</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Treated</title>
          <description>Treatment with Humatrope for improvement of growth.</description>
        </group>
        <group group_id="E2">
          <title>Untreated</title>
          <description>No treatment with somatropin in participants with a history of neoplasia or in those with any SHOX deficiency-related disorder.</description>
        </group>
        <group group_id="E3">
          <description>Treatment with Humatrope unknown.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA E18.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="547" subjects_at_risk="21177"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="306"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Aplastic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Immune thrombocytopenic purpura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Thrombotic microangiopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary valve disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arnold-chiari malformation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Brachydactyly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Coarctation of the aorta</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Congenital aplastic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cryptorchism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Imperforate hymen</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intestinal malrotation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Laryngomalacia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oculoauriculovertebral dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Prader-willi syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rathke's cleft cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tourette's disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ventricular septal defect</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Middle ear disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tympanic membrane disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Adrenocortical insufficiency acute</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diabetes insipidus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Precocious puberty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Secondary adrenocortical insufficiency</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Secondary hypogonadism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Deformity of orbit</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Iridocyclitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Keratoconus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oculogyric crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Papilloedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Strabismus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oesophageal rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumatosis intestinalis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rectal fissure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="22" subjects_affected="16" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anaphylactoid reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Kidney transplant rejection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Brain abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Catheter site cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cellulitis orbital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cholangitis infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastroenteritis rotavirus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>H1n1 influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemophilus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatitis a</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatitis viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Herpes zoster disseminated</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Infectious mononucleosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Infective pulmonary exacerbation of cystic fibrosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Latent tuberculosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Lymph node tuberculosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningitis aseptic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningitis bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningitis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Mycoplasma infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="22" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia mycoplasmal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia respiratory syncytial viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="11" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rhinovirus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rotavirus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Shunt infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Radiation injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Shunt malfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Shunt occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Splenic injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sports injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Traumatic renal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Body temperature fluctuation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Insulin-like growth factor increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Salmonella test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Staphylococcus test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="23" subjects_affected="18" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tetany</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Weight gain poor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bone cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bone development abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bone disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bone lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Epiphysiolysis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Extremity contracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Juvenile idiopathic arthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Kyphoscoliosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Kyphosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Limb asymmetry</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Limb deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Posture abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acoustic neuroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Acute lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anaplastic astrocytoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Astrocytoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Burkitt's lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Choroid neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Craniopharyngioma</sub_title>
                <counts group_id="E1" events="22" subjects_affected="19" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ependymoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ewing's sarcoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Fibrous cortical defect</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Glioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Inflammatory pseudotumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Medulloblastoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Medulloblastoma recurrent</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neoplasm progression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neoplasm recurrence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neuroblastoma recurrent</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neurofibroma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Optic glioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteochondroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteosarcoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ovarian fibroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ovarian germ cell teratoma benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pancreatic neuroendocrine tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peripheral nerve sheath tumour malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pituitary tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pituitary tumour recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Primitive neuroectodermal tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Prolactinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sarcoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Spinal cord neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Testicular germ cell cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired epileptic aphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Benign intracranial hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Conus medullaris syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Dyslalia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Febrile convulsion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hemiplegic migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic seizure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Infantile spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Moyamoya disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Paraplegia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Petit mal epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tethered cord syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Unresponsive to stimuli</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anger</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anorexia nervosa</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Asperger's disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Conversion disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Eating disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Obsessive-compulsive disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Phobia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Reactive attachment disorder of infancy or early childhood</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Suicidal behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypertonic bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Post streptococcal glomerulonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Fallopian tube cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Testicular torsion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Adenoidal hypertrophy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Allergic respiratory symptom</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Asthmatic crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nasal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary artery dilatation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Snoring</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tonsillar haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tonsillar hypertrophy</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Purpura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Purpura fulminans</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Puberty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Adenoidectomy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Adenotonsillectomy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arthrodesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bone marrow transplant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cleft lip repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ear operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Eye operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hydrocele operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Jejunostomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Leg amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Limb operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Medical device implantation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningioma surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nasal septal operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oesophagogastric fundoplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oophorectomy bilateral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Orchidectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Orchidopexy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteotomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal transplant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Salpingo-oophorectomy bilateral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Scoliosis surgery</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Spinal fusion surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tenotomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tonsillectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ventriculo-peritoneal shunt</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wisdom teeth removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Angiodysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.2</frequency_threshold>
        <default_vocab>MedDRA E18.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6180" subjects_at_risk="21177"/>
                <counts group_id="E2" subjects_affected="126" subjects_at_risk="306"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Turner's syndrome</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="8458"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="100" subjects_affected="99" subjects_at_risk="21177"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" events="50" subjects_affected="48" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Delayed puberty</sub_title>
                <counts group_id="E1" events="193" subjects_affected="192" subjects_at_risk="21177"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diabetes insipidus</sub_title>
                <counts group_id="E1" events="49" subjects_affected="49" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypogonadism</sub_title>
                <counts group_id="E1" events="131" subjects_affected="129" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypopituitarism</sub_title>
                <counts group_id="E1" events="85" subjects_affected="85" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="391" subjects_affected="391" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Precocious puberty</sub_title>
                <counts group_id="E1" events="266" subjects_affected="262" subjects_at_risk="21177"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Primary hypothyroidism</sub_title>
                <counts group_id="E1" events="195" subjects_affected="193" subjects_at_risk="21177"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Secondary hypogonadism</sub_title>
                <counts group_id="E1" events="97" subjects_affected="97" subjects_at_risk="21177"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Secondary hypothyroidism</sub_title>
                <counts group_id="E1" events="314" subjects_affected="312" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="147" subjects_affected="133" subjects_at_risk="21177"/>
                <counts group_id="E2" events="16" subjects_affected="11" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="153" subjects_affected="147" subjects_at_risk="21177"/>
                <counts group_id="E2" events="17" subjects_affected="13" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="74" subjects_affected="69" subjects_at_risk="21177"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="58" subjects_affected="57" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="71" subjects_affected="65" subjects_at_risk="21177"/>
                <counts group_id="E2" events="17" subjects_affected="12" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="138" subjects_affected="115" subjects_at_risk="21177"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="55" subjects_affected="53" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="77" subjects_affected="73" subjects_at_risk="21177"/>
                <counts group_id="E2" events="16" subjects_affected="14" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" events="55" subjects_affected="53" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>No adverse event</sub_title>
                <counts group_id="E1" events="110" subjects_affected="110" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="148" subjects_affected="118" subjects_at_risk="21177"/>
                <counts group_id="E2" events="12" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="45" subjects_affected="44" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Multiple allergies</sub_title>
                <counts group_id="E1" events="70" subjects_affected="70" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" events="104" subjects_affected="99" subjects_at_risk="21177"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="112" subjects_affected="90" subjects_at_risk="21177"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="89" subjects_affected="70" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="140" subjects_affected="123" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="131" subjects_affected="108" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="108" subjects_affected="78" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="264" subjects_affected="199" subjects_at_risk="21177"/>
                <counts group_id="E2" events="15" subjects_affected="10" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="55" subjects_affected="51" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" events="82" subjects_affected="70" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="74" subjects_affected="62" subjects_at_risk="21177"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="111" subjects_affected="99" subjects_at_risk="21177"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="279" subjects_affected="199" subjects_at_risk="21177"/>
                <counts group_id="E2" events="33" subjects_affected="20" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="58" subjects_affected="49" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" events="44" subjects_affected="43" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood corticotrophin decreased</sub_title>
                <counts group_id="E1" events="51" subjects_affected="51" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="66" subjects_affected="64" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vitamin d deficiency</sub_title>
                <counts group_id="E1" events="143" subjects_affected="135" subjects_at_risk="21177"/>
                <counts group_id="E2" events="40" subjects_affected="36" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="425" subjects_affected="373" subjects_at_risk="21177"/>
                <counts group_id="E2" events="23" subjects_affected="16" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="92" subjects_affected="87" subjects_at_risk="21177"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="52" subjects_affected="52" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" events="59" subjects_affected="58" subjects_at_risk="21177"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="128" subjects_affected="111" subjects_at_risk="21177"/>
                <counts group_id="E2" events="17" subjects_affected="10" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" events="416" subjects_affected="412" subjects_at_risk="21177"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" events="134" subjects_affected="129" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="45" subjects_affected="43" subjects_at_risk="21177"/>
                <counts group_id="E2" events="11" subjects_affected="6" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="680" subjects_affected="594" subjects_at_risk="21177"/>
                <counts group_id="E2" events="67" subjects_affected="36" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="64" subjects_affected="63" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="89" subjects_affected="87" subjects_at_risk="21177"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" events="43" subjects_affected="43" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="65" subjects_affected="65" subjects_at_risk="21177"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Attention deficit/hyperactivity disorder</sub_title>
                <counts group_id="E1" events="389" subjects_affected="389" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="81" subjects_affected="81" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="48" subjects_affected="47" subjects_at_risk="21177"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Enuresis</sub_title>
                <counts group_id="E1" events="101" subjects_affected="95" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Amenorrhoea</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="8458"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="166"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="8458"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="166"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" events="89" subjects_affected="87" subjects_at_risk="12692"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Menstruation irregular</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="8458"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="166"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ovarian failure</sub_title>
                <counts group_id="E1" events="85" subjects_affected="85" subjects_at_risk="8458"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="166"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="180" subjects_affected="174" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="75" subjects_affected="70" subjects_at_risk="21177"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="40" subjects_affected="38" subjects_at_risk="21177"/>
                <counts group_id="E2" events="9" subjects_affected="6" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" events="69" subjects_affected="61" subjects_at_risk="21177"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="55" subjects_affected="55" subjects_at_risk="21177"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" events="135" subjects_affected="130" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="75" subjects_affected="73" subjects_at_risk="21177"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="48" subjects_affected="47" subjects_at_risk="21177"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="47" subjects_affected="45" subjects_at_risk="21177"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="306"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chief Medical Officer</name_or_title>
      <organization>Eli Lilly and Company</organization>
      <phone>800-545-5979</phone>
      <email>ClinicalTrials.gov@lilly.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

